Nalaganje...
Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma
This phase II study was designed to evaluate the activity and safety of a combination of irinotecan, docetaxel and oxaliplatin in metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. Forty patients with measurable distant metastasis received irinotecan 150 mg m(−2) and docetaxel 60 ...
Shranjeno v:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2007
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2360369/ https://ncbi.nlm.nih.gov/pubmed/17667920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603917 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|